The frequencies of ALK rearrangements ranged respectively from 0% to 30.65% and from 2.63% to 37.04% in male (397/7689) and female (507/6627) patients with NSCLC based on 50 articles. This evidence concerns the gene ALK and non-small cell lung carcinoma.